Literature DB >> 17917073

Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification ("Fahr's disease").

J R M Oliveira1, M J Sobrido, E Spiteri, S Hopfer, G Meroni, E Petek, M Baquero, D H Geschwind.   

Abstract

Basal ganglia calcification (striatopallidodentate calcifications) can be caused by several systemic and neurological disorders. Familial Idiopathic Basal Ganglia Calcification (IBGC, "Fahr's disease"), is characterized by basal ganglia and extrabasal ganglia calcifications, parkinsonism and neuropsychiatric symptoms. Because of an increased use of neuroimaging procedures, calcifications of the basal ganglia are visualized more often and precociously. In 1999, a major American family with IBGC was linked to a locus on chromosome 14q (IBGC1). Another small kindred, from Spain, has also been reported as possibly linked to this locus. Here we report the main findings of the first 30 candidate genes sequenced at the IBGC1 locus during the process of searching for a mutation responsible for familial IBGC. During the sequencing process, we identified a heterozygous nonsynonymous single nucleotide polymorphism (exon 20 of the MGEA6/c-TAGE gene) shared by the affected and not present in the controls. This SNP was randomly screened in the general population (348 chromosomes) in a minor allele frequency to 0.0058 (two heterozygous among 174 subjects). Another variation in this gene, in the exon 9, was found in the Spanish family. However, this variation was extremely common in the general population. Functional and population studies are necessary to fully access the implications of the MGEA6 gene in familial IBGC, and a complete sequencing of the IBGC1 locus will be necessary to define a gene responsible for familial IBGC.

Entities:  

Mesh:

Year:  2007        PMID: 17917073

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  19 in total

Review 1.  Functions of WW domains in the nucleus.

Authors:  M Sudol; K Sliwa; T Russo
Journal:  FEBS Lett       Date:  2001-02-16       Impact factor: 4.124

2.  Paranoid delusions and cognitive impairment suggesting Fahr's disease.

Authors:  Shamim V Shakibai; Joel P Johnson; James A Bourgeois
Journal:  Psychosomatics       Date:  2005 Nov-Dec       Impact factor: 2.386

3.  Symmetrical intracerebral and intracerebellar calcification ("Fahr's disease").

Authors:  Ursula Schmidt; Kay Mursch; Marc-Eric Halatsch
Journal:  Funct Neurol       Date:  2005 Jan-Mar

4.  MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.

Authors:  Nicole Comtesse; Isolde Niedermayer; Brenda Glass; Dirk Heckel; Esther Maldener; Wolfgang Nastainczyk; Wolfgang Feiden; Eckart Meese
Journal:  Oncogene       Date:  2002-01-10       Impact factor: 9.867

5.  Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).

Authors:  J R M Oliveira; E Spiteri; M J Sobrido; S Hopfer; J Klepper; T Voit; J Gilbert; Z K Wszolek; D B Calne; A J Stoessl; M Hutton; B V Manyam; F Boller; M Baquero; D H Geschwind
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

6.  Calcification in the basal ganglia with chronic active Epstein-Barr virus infection.

Authors:  M Morita; I Tsuge; H Matsuoka; Y Ito; T Itosu; M Yamamoto; T Morishima
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

7.  The MGEA6 multigene family has an active locus on 14q and at least nine pseudogenes on different chromosomes.

Authors:  N Comtesse; K Reus; E Meese
Journal:  Genomics       Date:  2001-07       Impact factor: 5.736

8.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide.

Authors:  M J Macias; M Hyvönen; E Baraldi; J Schultz; M Sudol; M Saraste; H Oschkinat
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

Review 9.  Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices.

Authors:  M S Sansom; H Weinstein
Journal:  Trends Pharmacol Sci       Date:  2000-11       Impact factor: 14.819

10.  Cloning, genomic structure, and expression profiles of TULIP1 (GARNL1), a brain-expressed candidate gene for 14q13-linked neurological phenotypes, and its murine homologue.

Authors:  Thomas Schwarzbraun; John B Vincent; Axel Schumacher; Daniel H Geschwind; Joao Oliveira; Christian Windpassinger; Lisa Ofner; Michael K Ledinegg; Peter M Kroisel; Klaus Wagner; Erwin Petek
Journal:  Genomics       Date:  2004-09       Impact factor: 5.736

View more
  9 in total

1.  Analysis of the CTAGE5 P521A variation with the risk of familial idiopathic basal ganglia calcification in an Iranian population.

Authors:  Kioomars Saliminejad; Fereshteh Ashtari; Koroosh Kamali; Haleh Edalatkhah; Hamid Reza Khorram Khorshid
Journal:  J Mol Neurosci       Date:  2012-10-05       Impact factor: 3.444

2.  Population and computational analysis of the MGEA6 P521A variation as a risk factor for familial idiopathic basal ganglia calcification (Fahr's disease).

Authors:  Roberta R Lemos; Danyllo F Oliveira; Mayana Zatz; João R M Oliveira
Journal:  J Mol Neurosci       Date:  2010-09-14       Impact factor: 3.444

Review 3.  Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients.

Authors:  Sara Bonazza; Chiara La Morgia; Paolo Martinelli; Sabina Capellari
Journal:  Neurol Sci       Date:  2011-04-09       Impact factor: 3.307

4.  2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family.

Authors:  Claudia Béu Volpato; Alessandro De Grandi; Ebba Buffone; Maurizio Facheris; Uwe Gebert; Günther Schifferle; Rudolf Schönhuber; Andrew Hicks; Peter P Pramstaller
Journal:  J Mol Neurosci       Date:  2009-11       Impact factor: 3.444

5.  Pure psychiatric presentation in a patient with Fahr's disease.

Authors:  Rosaria Renna; Francesca Plantone; Domenico Plantone
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

6.  Bilateral strio-pallido-dentate calcinosis (Fahr's disease): report of seven cases and revision of literature.

Authors:  Elisabetta Savino; Cecilia Soavi; Eleonora Capatti; Massimo Borrelli; Giovanni B Vigna; Angelina Passaro; Giovanni Zuliani
Journal:  BMC Neurol       Date:  2016-09-08       Impact factor: 2.474

7.  Mutation Analysis of SLC20A2 and SPP2 as Candidate Genes for Familial Idiopathic Basal Ganglia Calcification.

Authors:  Fereshteh Ashtari; Kioomars Saliminejad; Ali Ahani; Koorosh Kamali; Zhamak Pahlevanzadeh; Hamid Reza Khorram Khorshid
Journal:  Avicenna J Med Biotechnol       Date:  2013-10

8.  Neuropsychiatric manifestations of Fahr's disease pathogenesis and potential for treatment.

Authors:  Raheel Mushtaq; Sheikh Shoib; M S V K Raju; Nilesh Naphade; Tabindah Shah; Alka Pawar
Journal:  Ind Psychiatry J       Date:  2013-07

9.  Prevalence of brain calcifications in a Brazilian cohort: A retrospective study in radiology services.

Authors:  Matheus Fernandes de Oliveira; Edison Barros E Silva; João Ricardo Mendes de Oliveira
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.